Xencor (XNCR) Interest Coverage Ratio (2013 - 2026)
Xencor's (XNCR) quarterly Interest Coverage Ratio came in at 0.85 in Q1 2026, up 83.02% year-on-year from 0.46 in Q1 2025, and down 138.76% on a QoQ basis from 2.18 in Q4 2025.
Xencor (XNCR) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Interest Coverage Ratio data on file, last reported at 0.85 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 83.02% year-over-year to 0.85 in Q1 2026; TTM through Mar 2026 was 2.31, a 19.26% increase from a year earlier, with the FY2025 full-year figure at 1.88, down 138.99% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 0.85, down from 2.18 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for XNCR reached as high as 38.69 in Q1 2022 and fell as low as 83.9 in Q1 2023.
- Historically, Interest Coverage Ratio has averaged 6.57 across 5 years, with a median of 0.86 in 2022.
- Across the five-year window, Interest Coverage Ratio slumped 718.29% in 2022 and jumped 662.59% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 44.55 in 2022, then surged by 90.03% to 4.44 in 2023, then jumped by 91.27% to 0.39 in 2024, then soared by 662.59% to 2.18 in 2025, then tumbled by 138.76% to 0.85 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.85 in Q1 2026, 2.18 in Q4 2025, and 0.49 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | -0.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.85 |
| Dec 31, 2025 | 2.18 |
| Sep 30, 2025 | -0.49 |
| Jun 30, 2025 | -0.34 |
| Mar 31, 2025 | -4.98 |
| Dec 31, 2024 | -0.39 |
| Sep 30, 2024 | -0.53 |
| Jun 30, 2024 | -1.66 |
| Mar 31, 2024 | -5.65 |
| Dec 31, 2023 | -4.44 |
| Sep 30, 2023 | -1.98 |
| Jun 30, 2023 | -0.58 |
| Mar 31, 2023 | -83.90 |
| Dec 31, 2022 | -44.55 |
| Sep 30, 2022 | -1.42 |
| Jun 30, 2022 | -0.86 |
| Mar 31, 2022 | 38.69 |
| Sep 30, 2021 | -0.76 |
| Jun 30, 2021 | 0.14 |
| Mar 31, 2021 | -31.41 |